South Korea Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

South Korea Healthcare, Regulatory and Reimbursement Landscape - CountryFocus



It, the industry analysis specialist, has released its latest report, South Korea Healthcare, Regulatory and Reimbursement Landscape - CountryFocus. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in South Korea. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

The South Korean pharmaceutical market increased from $20.3B in 2011 to $26.4B in 2018, at a Compound Annual Growth Rate (CAGR) of 3.8%. It is forecast to reach $34.3B by 2025. The South Korean biopharmaceutical market was $2B in 2013 that increased at a YoY (Year on Year) growth rate of 21.95% to reach $2.5B in 2018. The South Korean medical device market was valued at $6.9B in 2015, which increased to $8.3B in 2019. The market is expected to grow at a CAGR of 4.8% from $8.7B in 2020 to $9.6B in 2022. South Korea has free trade agreements with the US, EU and India. These agreements help in eliminating trade barriers and attracting foreign investment.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in South Korea, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Merck, Novartis, AstraZeneca, Daewoong Pharmaceutical, and Celltrion
- Profiles and SWOT analyses of the major players in the medical device market: GE Healthcare, Stryker, Boston Scientific, and Alcon.
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the countrys healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the countrys healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the South Korean healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving South Koreas healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact South Koreas healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

2 Executive Summary
2.1 Executive Summary
2.2 Key Highlights
2.3 Key Events: South Korean Pharmaceutical News, 2014-2020
2.4 Key Events: South Korean Pharmaceutical Market
2.5 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.6 Key Events: Mergers and Acquisitions
2.7 Country Profile, South Korea, 2019
3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Drug Approvals
3.3 Pharmaceutical Market - Exports
3.4 Pharmaceutical Market - Imports
3.5 Pharmaceutical Supply Channels, South Korea
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, South Korea
3.7 COVID-19 Epidemiology, South Korea
3.8 Government Response to Mitigate COVID-19
3.9 COVID-19 Impact and Developments in Healthcare Market, South Korea
3.10 Pharmaceutical Market - Major Players
4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Device Market - Major Segments
4.3 Medical Device Market - Major Players
5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6 Deal Analysis
6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, South Korea 2019-2020
6.2 Deal Analysis: M&A, VF and PE Deals, Medical Devices, South Korea 2019-2020
7 HealthTech Landscape
7.1 HealthTech Landscape, South Korea
7.2 Digital Statistics, South Korea
7.3 Adoption of Technology in Healthcare, South Korea
7.4 HealthTech Deals Landscape, South Korea
7.5 Key HealthTech Deals, South Korea
7.6 Regulatory Scenario Covering Use of Technology in Healthcare
7.5 HealthTech Landscape- South Korea- Benefits and Risks
8 Market Access
8.1 Overview of Healthcare System, South Korea
8.2 Reimbursement Process (Drug and Medical Device), South Korea
8.3 Overview of Insurance Providers (Public and Private), South Korea
8.4 Healthcare Spending and Health Price Index, South Korea
8.5 Pricing Policies, South Korea
8.6 Regulatory Landscape, South Korea
8.6.1 Market Authorization for Pharmaceutical Drugs, South Korea
8.6.2 Market Authorization for Generic Drugs, South Korea
8.6.3 Market Authorization for OTC Drugs, South Korea
8.6.4 Market Authorization for Biosimilars, South Korea
8.6.5 Market Authorization for Medical Devices, South Korea
8.6.6 Licensing Process for Pharmaceutical Exports and Imports
8.6.7 Intellectual Property Rights, Patent, South Korea
8.6.8 Clinical Trial Regulations, South Korea
8.6.9 Pharmaceutical Clinical Trials Landscape, South Korea
8.6.10 Medical Device Clinical Trials Landscape, South Korea
8.6.11 Pharmaceutical Advertising Regulations, South Korea
8.6.12 Pharmacy Regulations, South Korea
8.6.13 Labeling and Packaging Regulations, South Korea
9 Country Healthcare Landscape
9.1 Major Healthcare Policies, South Korea
9.2 Healthcare Facilities, South Korea
9.3 Healthcare Parameters, South Korea
9.4 Life Expectancy and Immunization Rate, South Korea
9.5 Environmental Health, South Korea
9.6 Healthcare Personnel, South Korea
9.7 Disease Burden, South Korea
9.8 Healthcare Expenditure
10 Trade Associations, South Korea
11 Trade Fairs, South Korea
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.1.4 Expert Panel
13.2 Bibliography
13.3 Contact Us
13.4 Disclaimer

List Of Tables

Table 1: Approved Biologics, South Korea, 2018
Table 2: Approved Biosimilars, South Korea, 2012-2018
Table 3: COVID-19 Indicators (Number of cases), Global and South Korea, 2020
Table 4: Major COVID 19 Pipeline Drugs, South Korea, 2020
Table 5: COVID-19 Clinical Trials, South Korea, 2020
Table 6: COVID-19 Diagnostic Equipment, South Korea, 2020
Table 7: Hospital Supplies Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2016
Table 8: Diagnostic Imaging Devices Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 9: Dental Devices Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 10: Ophthalmic Devices Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 11: General Surgery Devices Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 12: National Insurance Contribution Rates, South Korea, 2019
Table 13: Long-Term Care Insurance System vs Previous Elderly Benefit Service System, South Korea, 2018
Table 14: Medical Products Fees, South Korea, 2018
Table 15: Medical Device Classification, South Korea, 2017
Table 16: Patent Fees, South Korea, 2020
Table 17: Trademark Fees, South Korea, 2018
Table 18: Drug Container and Package Information, South Korea, 2017
Table 19: Package Insert Information, South Korea, 2017
Table 20: Trade Fairs, 2020

List Of Figures

Figure 1: Pharmaceutical Market, South Korea, Revenue ($B), 2012-2018
Figure 2: Medical Device Market, South Korea, Revenue ($B), 2015-2020
Figure 3: Country Profile, South Korea, 2019
Figure 4: Pharmaceutical Market, South Korea, Revenue ($B), 2011-2018
Figure 5: Pharmaceutical Market, South Korea, Revenue Forecast ($B), 2019-2025
Figure 6: Drug Approvals and Notifications (number), South Korea, 2010-2018
Figure 7: Drug Approvals by Therapeutic Class, South Korea, 2018
Figure 8: Pharmaceutical Exports ($M), South Korea, 2010-2019
Figure 9: Top Export Partners, South Korea, 2019
Figure 10: Pharmaceutical Imports ($B), South Korea, 2010-2019
Figure 11: Top Import Partners, South Korea, 2019
Figure 12: Process of Assigning KD Code, South Korea, 2018
Figure 13: Drug Supply and Report Process of Drug Transaction Records, South Korea, 2016
Figure 14: Biopharmaceutical Market, South Korea, Revenue ($B), 2010-2018
Figure 15: Top 5 Biopharmaceuticals (by production amount ton), South Korea, 2017
Figure 16: Major Bio - Health Clusters, South Korea, 2019
Figure 17: OTC Market, South Korea, Major Categories ($M), 2019
Figure 18: OTC Market, South Korea, Revenue ($M), 2010-2019
Figure 19: Therapeutic Area by Sales per Capita ($/person), South Korea, 2018
Figure 20: Therapeutic Area by Pharmaceutical Consumption (DDD/1,000 person/day), South Korea, 2018
Figure 21: COVID-19 (Number of cases), South Korea, 2020
Figure 22: COVID-19 (Number of deaths), South Korea, 2020
Figure 23: COVID-19 Monetary Stimulus, South Korea, 2020
Figure 24: COVID-19 Fiscal Stimulus, South Korea, 2020
Figure 25: Pharmaceutical Market, Major Players, 2018
Figure 26: Medical Device Market, South Korea, Revenue ($B), 2015-2020
Figure 27: Medical Device Market, South Korea, Revenue Forecast ($B), 2021-2025
Figure 28: Medical Devices Market, Major Segments (%), South Korea, 2019
Figure 29: Hospital Supplies Market, South Korea, Revenue ($M), 2015-2022
Figure 30: Hospital Supplies Market, South Korea, Market Share of Major Players (%), 2016
Figure 31: Diagnostic Imaging Devices Market, South Korea, Revenue ($M), 2015-2022
Figure 32: Diagnostic Imaging Devices Market, South Korea, Market Share of Major Players (%), 2019
Figure 33: Dental Devices Market, South Korea, Revenue ($B), 2015-2022
Figure 34: Dental Devices Market, South Korea, Market Share of Major Players (%), 2018
Figure 35: Ophthalmic Devices Market, South Korea, Revenue ($M), 2015-2022
Figure 36: Ophthalmic Devices Market, South Korea, Market Share of Major Players (%), 2015
Figure 37: General Surgery Devices Market, South Korea, Revenue ($M), 2015-2022
Figure 38: General Surgery Devices Market, South Korea, Market Share of Major Companies (%), 2019
Figure 39: Diagnostic Market, South Korea, Revenue ($M), 2015-2020
Figure 40: Diagnostic Market, South Korea, Revenue ($M), 2021-2025
Figure 41: Medical Device Market, South Korea, Revenue ($B) of Major Companies, 2019
Figure 42: Deal Value and Deal Count, Pharmaceutical Market, South Korea, 2019-2020
Figure 43: Deal Value and Deal Count Quarterly, Pharmaceutical Market, South Korea, 2019-2020
Figure 44: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, South Korea, 2019-2020
Figure 45: Top Therapy Areas by Deal Value, Pharmaceutical Market, South Korea, 2019-2020

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available